Literature DB >> 11529209

Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women.

D Hubacher1, R Lara-Ricalde, D J Taylor, F Guerra-Infante, R Guzmán-Rodríguez.   

Abstract

BACKGROUND: Previous studies of intrauterine devices (IUDs), many of which are no longer in use, suggested that they might cause tubal infertility. The concern that IUDs that contain copper--currently the most commonly used type--may increase the risk of infertility in nulligravid women has limited the use of this highly effective method of birth control.
METHODS: We conducted a case-control study of 1895 women recruited between 1997 and 1999. We enrolled 358 women with primary infertility who had tubal occlusion documented by hysterosalpingography, as well as 953 women with primary infertility who did not have tubal occlusion (infertile controls) and 584 primigravid women (pregnant controls). We collected information on the women's past use of contraceptives, including copper IUDs, previous sexual relationships, and history of genital tract infections. Each woman's blood was tested for antibodies to Chlamydia trachomatis. We used stratified analyses and logistic regression to assess the association between the previous use of a copper IUD and tubal occlusion.
RESULTS: In analyses involving the women with tubal occlusion and the infertile controls, the odds ratio for tubal occlusion associated with the previous use of a copper IUD was 1.0 (95 percent confidence interval, 0.6 to 1.7). When the primigravid women served as the controls, the corresponding odds ratio was 0.9 (95 percent confidence interval, 0.5 to 1.6). Tubal infertility was not associated with the duration of IUD use, the reason for the removal of the IUD, or the presence or absence of gynecologic problems related to its use. The presence of antibodies to chlamydia was associated with infertility.
CONCLUSIONS: The previous use of a copper IUD is not associated with an increased risk of tubal occlusion among nulligravid women whereas infection with C. trachomatis is.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11529209     DOI: 10.1056/NEJMoa010438

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  46 in total

Review 1.  An update on pelvic inflammatory disease.

Authors:  J D C Ross
Journal:  Sex Transm Infect       Date:  2002-02       Impact factor: 3.519

Review 2.  Recent developments in hormonal contraception.

Authors:  Eleanor A Drey; Philip D Darney
Journal:  Rev Endocr Metab Disord       Date:  2002-09       Impact factor: 6.514

3.  Barriers to Intrauterine Device Uptake in a Rural Setting in Ghana.

Authors:  Nuriya Robinson; Mosa Moshabela; Lydia Owusu-Ansah; Chisina Kapungu; Stacie Geller
Journal:  Health Care Women Int       Date:  2014-10-14

Review 4.  [The family doctor facing IUD insertion].

Authors:  L Arribas-Mir; A Ortega Del Moral; M Jódar-Reyes
Journal:  Aten Primaria       Date:  2005-12       Impact factor: 1.137

5.  Barriers to contraceptive use in product labeling and practice guidelines.

Authors:  Daniel Grossman; Charlotte Ellertson; Katrina Abuabara; Kelly Blanchard; Francisco T Rivas
Journal:  Am J Public Health       Date:  2006-01-31       Impact factor: 9.308

6.  Contraception for Adolescents: Focusing on Long-Acting Reversible Contraceptives (LARC) to Improve Reproductive Health Outcomes.

Authors:  Bliss Kaneshiro; Jennifer Salcedo
Journal:  Curr Obstet Gynecol Rep       Date:  2015-01-28

7.  Fear of intrauterine contraception among adolescents in New York City.

Authors:  Julia Potter; Susan E Rubin; Peter Sherman
Journal:  Contraception       Date:  2014-01-21       Impact factor: 3.375

8.  Recommendations for intrauterine contraception: a randomized trial of the effects of patients' race/ethnicity and socioeconomic status.

Authors:  Christine Dehlendorf; Rachel Ruskin; Kevin Grumbach; Eric Vittinghoff; Kirsten Bibbins-Domingo; Dean Schillinger; Jody Steinauer
Journal:  Am J Obstet Gynecol       Date:  2010-07-02       Impact factor: 8.661

Review 9.  Contraception for HIV-Infected Adolescents.

Authors:  Athena P Kourtis; Ayesha Mirza
Journal:  Pediatrics       Date:  2016-09       Impact factor: 7.124

10.  Long-term safety, efficacy, and patient acceptability of the intrauterine Copper T-380A contraceptive device.

Authors:  Bliss Kaneshiro; Tod Aeby
Journal:  Int J Womens Health       Date:  2010-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.